Array of Oncology Consulting Services

Tailored consulting solutions enabling oncology companies in taking critical decisions

  • Forecasting/Opportunity Assessment

    BD&L opportunity

    Target patient identification

    Market forecast

    Pipeline/in-line product forecast

    Bottom-up, top-down forecast

    User-friendly dynamic forecasting model to facilitate scenario planning

    Choosing short-range and long-range forecast optionsy

    Analog analysis and benchmarking

  • Competitive Intelligence

    Pipeline Insights

    Clinical and commercial strategy

    Trial intelligence

    Disease landscaping

    Competitive landscape assessment

    Asset prioritization

    Indication prioritization

  • Conference coverage

    Supporting clients on a specific target or indication coverage

    Providing timely intelligence

    Extensive pre and post-conference support by screening, analyzing and identifying key abstracts

    Providing high-value clinical and commercial analytical insight around data presented

  • Market intelligence

    Monitoring performance reports

    Key performance indicators (KPI) dashboard

    Value/Volume analysis

    Data to insight

    Sales/Spending analysis

    Prescription pattern analysis

    Promotional data analysis

  • Real-world evidence

    Claim and prescription data analysis

    Patient switch analysis

    Gauging source of business

    Analyzing treatment pattern and sequencing

    Measuring safety and efficacy outcomes

    Tracking burden of illness

  • Pricing Analytics

    Providing country-specific pricing scenario

    Analyzing duration of treatment and per-unit cost from real-world studies and trial enrollment

    Analyzing peer-reviewed articles to identify pricing benchmarks, payers and reimbursement scenario

  • Portfolio Optimizatio

    Strategizing for product portfolio

    Providing continuous support in terms of clinical and commercial rationale about molecule, companies, technology, generic/biosimilar opportunities

  • KOL Engagement

    Answering key intelligence questions based on interviews with physicians, stakeholders, company sources, analysts, payers, academic professionals, and patient advocacy groups

BD&L opportunity

Target patient identification

Market forecast

Pipeline/in-line product forecast

Bottom-up, top-down forecast

User-friendly dynamic forecasting model to facilitate scenario planning

Choosing short-range and long-range forecast optionsy

Analog analysis and benchmarking

Pipeline Insights

Clinical and commercial strategy

Trial intelligence

Disease landscaping

Competitive landscape assessment

Asset prioritization

Indication prioritization

Supporting clients on a specific target or indication coverage

Providing timely intelligence

Extensive pre and post-conference support by screening, analyzing and identifying key abstracts

Providing high-value clinical and commercial analytical insight around data presented

Monitoring performance reports

Key performance indicators (KPI) dashboard

Value/Volume analysis

Data to insight

Sales/Spending analysis

Prescription pattern analysis

Promotional data analysis

Claim and prescription data analysis

Patient switch analysis

Gauging source of business

Analyzing treatment pattern and sequencing

Measuring safety and efficacy outcomes

Tracking burden of illness

Providing country-specific pricing scenario

Analyzing duration of treatment and per-unit cost from real-world studies and trial enrollment

Analyzing peer-reviewed articles to identify pricing benchmarks, payers and reimbursement scenario

Strategizing for product portfolio

Providing continuous support in terms of clinical and commercial rationale about molecule, companies, technology, generic/biosimilar opportunities

Answering key intelligence questions based on interviews with physicians, stakeholders, company sources, analysts, payers, academic professionals, and patient advocacy groups

Case studies

Explore our success stories to gain rich insights into the ever-evolving oncology domain
and discover the best-in-class solutions to accelerate the business growth

Market Assessment

A global pharmaceutical company wished to evaluate the market value of an asset obtained by acquiring a mid-cap company. The new drug class showed the potential to target multiple tumors in combination with their in-house immune checkpoint inhibitor (CPI).

  • Extensive Secondary Research
  • Extensive Primary Research

Discover More

Epidemiology Assessment

A client based in the US wanted the epidemiology assessment to understand the percentage of solid organ transplant recipients who develop Cutaneous Squamous Cell Carcinoma (cSCC) for 15 countries, including the US, European countries, and countries from APAC.

  • Secondary Assessment
  • Primary Assessment

Discover More

Competitive Intelligence

A global pharmaceutical company desired a web-based, robust and simplified, and user-friendly interactive dashboard to help their top executive track the evolving CI landscape in HR+ HER2-ve Breast Cancer.

  • Integrative approach
  • CI and Business analytics tools to include multiple types of interactive charts

Discover More

Reports

Newsletter / whitepaper

Unlock the significant assessment challenges that oncology researchers should be aware of in order to understand the specifics of the oncology market land space and to improve market research and growth.

Delveinsight's Blog

We bring you perspectives on the latest oncology- topics through our blog series, including information on the latest trends in cancer treatment, upcoming technologies in cancer diagnosis and treatment, emerging breakthrough therapies, market forecasts, latest commercial happenings and their impact, and other resources for oncology researchers, cancer patients, and their families.

Relevant Healthcare Expertise

  • Experience in working on >20 tumor types
  • In-house epidemiology and competitive intelligence database of oncology indications

Differentiators

  • Tailored approach to address need of the client
  • Region specific nuances from pricing to patent exclusivity
  • Value-addition and triangulation of data through extensive Primary Intelligence Research
  • Complimentary analyst support post project delivery

DelveInsight Strategic Support

  • Extensive coverage of in-depth analysis of market trends, key drivers & barriers, evolving market scenarios, to help make informed strategic decisions
  • Rigorous analysis to provide reliable facts, providing inputs for highly accurate market size forecasts and projections, helping in identification of white spaces for revenue growth, bridging data gap in oncology segments

Proven Record

  • DelveInsight has supported top Pharma companies in making strategic decisions
  • Compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and participants across the value chain
  • Strict quality checks before the final delivery
  • Experience in working on >20 tumor types
  • In-house epidemiology and competitive intelligence database of oncology indications
  • Extensive Primary Intelligence Research
  • Current and future estimates
  • Best estimates in product and market forecasts

Request For Proposal

*I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.